Advancing a Botanical Drug Product into Phase 2
Published on: 01/10/2026
Advancing a botanical-derived product into clinical development presents a distinctive quality and CMC challenge. Unlike a conventional synthetic drug substance, a botanical-derived product may originate from naturally variable material
Case Study: Advancing a Botanical-Derived Drug Product into Phase 2 Clinical Development